Document is current
Any future updates will be listed below
-
Authors
Frändemark, Åsa
Törnblom, Hans
Simrén, Magnus
Jakobsson, Sofie
-
Funding
Funding for this research was provided by:
The Swedish Research Council (13409)
The Swedish Research Council (21691)
The Swedish Research Council (21692)
AFA Försäkring (dnr 190087)
The Faculty of Medicine, Sahlgrenska Academy, University of Gothenburg
Centre for Person-Centred Care (GPCC), Sahlgrenska Academy, University of Gothenburg
University of Gothenburg
- License Information
-
More Information
Article History
Received: 9 November 2021
Accepted: 15 February 2022
First Online: 19 February 2022
Declarations
:
: The study was approved by The Regional ethical review board in Gothenburg (diary number 366-15) and followed the ethical principles of the Helsinki declaration. All participants gave their verbal and written informed consent before the start of any study related procedures.
: Not applicable.
: ÅF and SJ have no competing interests. HT has served as Consultant/Advisory Board member for Allergan, Almiral and Shire. MS has served as a Consultant/Advisory Board member for Danone Nutricia Research, Ironwood, Menarini, Biocodex, Genetic Analysis AS, Glycom, Tillotts, Arena, Kyowa Kirin, Adnovate, and Atnahs Pharma, and as a speaker for Tillotts, Menarini, Kyowa Kirin, Takeda, Shire, Biocodex, Alimentary Health, AlfaSigma, Sanofi and Falk Foundation.
